Overblog
Edit post Follow this blog Administration + Create my blog
Magnify Reads

Get the latest updates and news on eight important domains in the world.

Quick Responsiveness to drive the Microfluidic Devices market between 2020-2030

Microfluidic devices find their presence in energy, biomedicals, chemicals and also the environment. The major benefits offered are low experiment to cost ratio along with quick response time. Another factor is “surface wettability”. Microfluidics implies high-throughput and experimentation screening involving a number of techniques. Microfluidic devices are used to process and manipulate small quantities of liquids by using channels possessing micrometre dimensions.

Initially, microfluidics was applied only in microbiology in the form of one of the tools for microanalysis as reagents and samples are required. However, now microfluidics is being implemented in life science as well. The biotechnology and pharmaceutical companies

By type, microfluidic devices consist of sensors, chips, and others. By application, microfluidic devices comprise diagnosis & treatment, pharmaceutical & life science research, and others. By end-user, the microfluidic devices constitute healthcare facilities, biotechnology and pharmaceutical companies, research institutes, and diagnostic centres.

The current scenario is such that cost-effective materials are being used to manufacture microfluidic sensors and chips. For the precise flow of the micro fluids in helping with effective diagnosis (of the ailment), cellular analysis, and drug delivery, the materials used are PDMS, silicone, glass. As glass proves to be brittle and expensive, OEMS these days go for cost-effective materials like paper, polymers to develop sensors and chips. Where robust, user-friendly, disposable, and flexible sensors and chips come into picture, paper turns out to be an utterly useful substrate.

Microfluidic sensors and chips are showing good functionalities regarding the conduction of specific experiments in biomedical vertical. A lab-on-a-chip allows rapid screening and high throughput regarding infectious diseases, achieving multiplex immunoassays, and detecting specific biomarkers. All these factors are expected to bolster the microfluidic devices market going forward.

North America, Europe, and the Asia-Pacific are the top-seeded regions herein (especially with lab-on-a-chip devices). The major players include uFluidix Perkin Elmer, Fluidigm, Micronit, Blacktrace Holdings Ltd., ALine, Inc., and Fluigent. Microfluidic chips from PerkinElmer Inc. is into the production of microfluidic chips for analysing proteins, nucleic acids, and small molecules.

Share this post
Repost0
To be informed of the latest articles, subscribe:
Comment on this post